Showing 681-690 of 19237 results for "".
Pig to Human Islet Cell Transplants
https://reachmd.com/programs/clinicians-roundtable/pig-to-human-islet-cell-transplants/1749/Islet Cell Transplantation is a promising treatment for diabetics however, if approved there will likely be a shortage of islet cells. Dr. Bernhard Hering shares his research with host Dr. Mark Nolan Hill about the use of pig tissue for human islet transplant.Is the Metabolic Syndrome More Than Just the Sum of Its Parts?
https://reachmd.com/programs/clinicians-roundtable/is-the-metabolic-syndrome-more-than-just-the-sum-of-its-parts/3183/The Metabolic Syndrome has been associated with an increased risk for developing diabetes and cardiovascular disease. Dr. Dariush Mozaffarian from the Division of Cardiovascular Medicine at Harvard Medical School will discuss his latest research on the Metabolic Syndrome in older adults highlightingYour COVID-19 Questions Answered
https://reachmd.com/programs/public-health-call/your-covid-19-questions-answered/11329/Are face masks and hand sanitizer effective? Should I cancel my upcoming travel plans? Get answers to these and other FAQs.Case-Based Approach: Optimizing Cardio-Kidney-Metabolic Outcomes in Individuals With T2D & CKD
https://reachmd.com/programs/cme/case-based-approach-optimizing-cardio-kidney-metabolic-outcomes-in-individuals-with-t2d-ckd/29906/Case-Based Approach: Optimizing Cardio-Kidney-Metabolic Outcomes in Individuals With T2D & CKDHypoglycemia & the Cardiovascular System: An Inside Look at Emerging Clinical Trial Data
https://reachmd.com/programs/diabetes-discourse/hypoglycemia-the-cardiovascular-system-an-inside-look-at-emerging-clinical-trial-data/12727/What kind of impact does severe hypoglycemia have on the cardiovascular system?Addressing Unmet Needs in Metastatic Uveal Melanoma
https://reachmd.com/programs/cme/addressing-unmet-needs-in-metastatic-uveal-melanoma/48980/Dive into what sets metastatic uveal melanoma (mUM) apart from cutaneous melanoma and why that matters for clinical decision-making. Explore how HLA A*02:01 typing informs patient selection and how bispecific TCR therapy is changing the treatment landscape. Real-world cases and clinical trial data bGlucose Control After Acute Myocardial Infarction
https://reachmd.com/programs/heart-matters/glucose-control-after-acute-myocardial-infarction/5259/Elevated blood sugar levels are quite common among even non-diabetic patients presenting with acute myocardial infarction (or AMI). Does lowering a patient's glucose level actually improve outcomes, and if so, what glucose-control therapies are most effective for these patients? Dr. Mikhail KosiboroPsychological Insulin Resistance
https://reachmd.com/programs/diabetes-discourse/psychological-insulin-resistance/6460/Insulin therapy can be challenging for both the patient with diabetes and their healthcare provider— from needle phobia to weight gain. How can healthcare providers shorten the learning curve to understanding insulin and its benefits? Join host Dr. Steven Edelman and his guest, Dr. Linda Siminerio,The Impact of Race and Ethnicity on Insulin Regimens
https://reachmd.com/programs/diabetes-discourse/the-impact-of-race-and-ethnicity-on-insulin-regimens/6295/The relationship of insulin regimens to race and ethnicity is a new and growing area of research to better understand and provide clinical care at a personalized level. What are significant differences and approaches to these patients' diabetes management? Join host Dr. Steven Edelman and his guest,NICE-SUGAR: Blood Glucose Levels in the ICU
https://reachmd.com/programs/diabetes-discourse/nice-sugar-blood-glucose-levels-in-the-icu/4825/Lowering blood sugar levels in critically ill patients is a widely embraced practice. But according to the results of the NICE-SUGAR study, lowering blood glucose levels in ICU patients may not be safe. Join host Dr. Steven Edelman and his guest, Dr. Irl Hirsch, professor of medicine and the Diabete